Evidence map›Paper›PMID 31282183›Full record

ArticleJournal of diabetes science and technology2020

Variation in Diabetes Management: A National Assessment of Primary Care Providers.

John W Peabody, Enrico de Belen, Jeffrey R Dahlen, Maria Czarina Acelajado, Mary T Tran, David R Paculdo

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners.Journal of clinical & translational endocrinology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

John W PeabodyUniversity of California San Francisco, CA, USA.ORCID 0000-0002-0210-9232
Enrico de BelenQURE Healthcare, San Francisco, CA, USA.
Jeffrey R DahlenHikari Dx, Inc., San Diego, CA, USA.
Maria Czarina AcelajadoQURE Healthcare, San Francisco, CA, USA.
Mary T TranQURE Healthcare, San Francisco, CA, USA.
David R PaculdoQURE Healthcare, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlucose control is monitored primarily through ordering HbA1c levels, which is problematic in patients with glycemic variability. Herein, we report on the management of these patients by board-certified primary care providers (PCPs) in the United States.

methodsWe measured provider practice in a representative sample of 156 PCPs. All providers cared for simulated patients with diabetes presenting with symptoms of glycemic variability. Provider responses were reviewed by trained clinicians against evidence-based care standards and accepted standard of care protocols.

resultsCare varied widely-overall quality of care averaged 51.3%±10.6%-with providers performing just over half the evidence-based practices necessary for their cases. More worryingly, provider identified the underlying etiology of the poor glycemic control only 36.3% of the time. HbA1c was routinely ordered in 91.3% of all cases but often (59.5%) inappropriately. Ordering other tests of glycemic control (done in 15% of cases) led to significant increases in identifying the etiology of the hyperglycemia. Correctly modifying their patient's treatment was more likely to occur if doctors first identified the underlying etiology (65.9% vs 49.0%,

conclusionDespite established evidence that HbA1c misses short-term changes in diabetes, we found PCPs consistently ordered HbA1c, rarely using other available blood tests. However, if the factors leading to poor glycemic control were recognized, PCPs were more likely to correctly alter their patient's hypoglycemic therapy.

Indexed as

Disease ManagementQuality of Health CareBlood GlucoseDiabetes MellitusEvidence-Based MedicineGlycated HemoglobinGlycemic ControlHealth Care SurveysHumansPrimary Health CareUnited StatesBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanA1Cclinical variabilitydiabetesglycemic controlquality of carestandardization of care

Identifiers

PMID31282183
PMCPMC7189162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.